NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/13/2023
Back to search
Official data from USPTO
BIOISIM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
06/13/2023
Trademark type
Word
Nice classes
42
Filing date
09/17/2021
Registration date
06/13/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2023
Last transaction
06/13/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/01/2018
First use in commerce
08/14/2018
Drawing code
4
Owner type
03
Owner location
San Francisco, CA, US
Examiner
SETTLES LEWIS, SHAILA E
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
VeriSIM Life Inc.
Representatives
Norm J. Rich FOLEY & LARDNER LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Software as a service (SAAS) services featuring software for modeling and the conducting of simulations of properties of drugs or chemicals including absorptionrelease ratebioavailabilitypharmacokinetics and pharmacodynamicssafetytoxicologyefficacy profilesroutes of administrationdose optimization; Software as a service (SAAS) services featuring software that allows for the prediction of drug-to-drug interactions; Software as a service (SAAS) services featuring software for the prediction of drug effects on animals and virtual patient populations; Software as a service (SAAS) services featuring software which allows researchers to adjust pharmacodynamic models to observed data and to then use the resulting fitted models to predict pharmacodynamic changes due to changes in routes of administrationdosedosage formdosing regimen of a drug or chemical; Software as a service (SAAS) services featuring software which allow for the prediction of absorption and systemic distribution/elimination for large molecules; Software as a service (SAAS) services featuring software that incorporates artificial intelligence and machine learning to predict the clinical efficacy of new drugs before human trials and accelerate pharmaceutical drug development and FDA approval
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/28/2023
PUBO
PUBLISHED FOR OPPOSITION
03/28/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/21/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/21/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/21/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/21/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/21/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/22/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/22/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/22/2022
GNRT
NON-FINAL ACTION E-MAILED
06/22/2022
CNRT
NON-FINAL ACTION WRITTEN
06/22/2022
DOCK
ASSIGNED TO EXAMINER
06/21/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/22/2021
NWAP
NEW APPLICATION ENTERED
09/21/2021
Continuous trademark protection
Get notified about every new filing that threatens BIOISIM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.